Literature DB >> 31271921

Complex relationships between perfluorooctanoate, body mass index, insulin resistance and serum lipids in young girls.

Cecily S Fassler1, Sara E Pinney2, Changchun Xie3, Frank M Biro4, Susan M Pinney5.   

Abstract

BACKGROUND: Perfluorooctanoate (PFOA) has been used extensively in the manufacture of both commercial and household products. PFOA serum concentrations have been associated with adverse health effects, including lower body mass in children and infants.
OBJECTIVE: To determine if there is an association between serum PFOA concentration and body mass, serum insulin and lipid profile in exposed young girls.
METHODS: We conducted a cross-sectional study of PFAS environmental biomarkers and insulin resistance in 6 to 8 year-old girls from Greater Cincinnati (n=353). In 2004-2006, blood samples were obtained to measure polyfluoroalkyl substances (PFAS), fasting insulin, glucose and lipids. Clinical exams included anthropometric measurements and pubertal maturation staging. Linear regression and mediation analyses, specifically structural equation modeling (SEM), were used to determine the strength and direction of the relationships between PFAS, pubertal maturation status, body mass index (BMI), cholesterol and insulin resistance.
RESULTS: The median PFOA (7.7ng/ml) was twice the National Health and Nutrition Examination Survey (2005-2006). Only PFOA, a PFAS sub-species, showed statistically significant relationships with the outcomes. In regression models, PFOA was associated with decreased BMI and waist-to-height ratio (p=0.0008; p=0.0343), HDL-cholesterol (p=0.0046) and had a borderline inverse association with the HOMA Index of insulin resistance (p=0.0864). In SEM, PFOA retained an inverse relationship with BMI (p<0.0001) but the relationships with HOMA and HDL-cholesterol were no longer statistically significant. Pubertal initiation (Tanner breast or pubic stage 2 or greater) and BMI were associated with increased HOMA Index (p<0.0001).
CONCLUSIONS: These findings suggest PFOA exposure in young girls affects both BMI and ultimately insulin resistance. In mediation analysis with puberty in the model, the direct effects of PFOA on insulin resistance and were reduced.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Cholesterol; Insulin resistance; Perfluorooctanoate; Structural equation modeling

Year:  2019        PMID: 31271921      PMCID: PMC6739842          DOI: 10.1016/j.envres.2019.108558

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  50 in total

1.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

Authors:  R L Hanson; R E Pratley; C Bogardus; K M Narayan; J M Roumain; G Imperatore; A Fagot-Campagna; D J Pettitt; P H Bennett; W C Knowler
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

2.  Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents.

Authors:  Neslihan Gungor; Rola Saad; Janine Janosky; Silva Arslanian
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

3.  Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction.

Authors:  Zsuzsanna Kuklenyik; Larry L Needham; Antonia M Calafat
Journal:  Anal Chem       Date:  2005-09-15       Impact factor: 6.986

Review 4.  Developmental origins of adult metabolic disease: concepts and controversies.

Authors:  Rebecca Simmons
Journal:  Trends Endocrinol Metab       Date:  2005-10       Impact factor: 12.015

Review 5.  Integration of physiological and molecular mechanisms of the developmental origins of adult disease: new concepts and insights.

Authors:  Michael E Symonds
Journal:  Proc Nutr Soc       Date:  2007-08       Impact factor: 6.297

6.  Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Authors:  A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

7.  Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia.

Authors:  M Zoltowska; E Ziv; E Delvin; S Stan; H Bar-On; R Kalman; E Levy
Journal:  Atherosclerosis       Date:  2001-07       Impact factor: 5.162

8.  Pubertal maturation in girls and the relationship to anthropometric changes: pathways through puberty.

Authors:  Frank M Biro; Anne W Lucky; Loretta A Simbartl; Bruce A Barton; Stephen R Daniels; Ruth Striegel-Moore; Shari S Kronsberg; John A Morrison
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

9.  Indexes of insulin resistance and secretion in obese children and adolescents: a validation study.

Authors:  Louise S Conwell; Stewart G Trost; Wendy J Brown; Jennifer A Batch
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

10.  Exposures among pregnant women near the World Trade Center site on 11 September 2001.

Authors:  Mary S Wolff; Susan L Teitelbaum; Paul J Lioy; Regina M Santella; Richard Y Wang; Robert L Jones; Kathleen L Caldwell; Andreas Sjödin; Wayman E Turner; Wei Li; Panos Georgopoulos; Gertrud S Berkowitz
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

View more
  8 in total

1.  Perfluoroalkyl substances and anthropomorphic measures in children (ages 3-11 years), NHANES 2013-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Henry G Abadin; Roberta Attanasio
Journal:  Environ Res       Date:  2020-04-15       Impact factor: 6.498

2.  Per- and polyfluoroalkyl substance mixtures and gestational weight gain among mothers in the Health Outcomes and Measures of the Environment study.

Authors:  Megan E Romano; Lisa G Gallagher; Melissa N Eliot; Antonia M Calafat; Aimin Chen; Kimberly Yolton; Bruce Lanphear; Joseph M Braun
Journal:  Int J Hyg Environ Health       Date:  2020-11-09       Impact factor: 5.840

Review 3.  Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review.

Authors:  Rachel Margolis; Karilyn E Sant
Journal:  J Xenobiot       Date:  2021-09-14

Review 4.  Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk.

Authors:  Katherine Roth; Michael C Petriello
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

5.  Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoroalkyl Substances Using Artificial Intelligence.

Authors:  Andreas-Marius Kaiser; Maryam Zare Jeddi; Maria Uhl; Florence Jornod; Mariana F Fernandez; Karine Audouze
Journal:  Toxics       Date:  2022-08-04

6.  Associations between exposure to perfluoroalkyl substances and body fat evaluated by DXA and MRI in 109 adolescent boys.

Authors:  Mathilde Lolk Thomsen; Louise Scheutz Henriksen; Jeanette Tinggaard; Flemming Nielsen; Tina Kold Jensen; Katharina M Main
Journal:  Environ Health       Date:  2021-06-28       Impact factor: 5.984

7.  PFAS Concentrations and Cardiometabolic Traits in Highly Exposed Children and Adolescents.

Authors:  Cristina Canova; Andrea Di Nisio; Giulia Barbieri; Francesca Russo; Tony Fletcher; Erich Batzella; Teresa Dalla Zuanna; Gisella Pitter
Journal:  Int J Environ Res Public Health       Date:  2021-12-07       Impact factor: 3.390

8.  Early-Life Exposure to Per- and Poly-Fluorinated Alkyl Substances and Growth, Adiposity, and Puberty in Children: A Systematic Review.

Authors:  Yun Jeong Lee; Hae Woon Jung; Hwa Young Kim; Yoon-Jung Choi; Young Ah Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-09       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.